Immunologic studies in cimetidine-induced nephropathy and polymyositis.
D000328:Adult; D001402:B-Lymphocytes; D001706:Biopsy; D002464:Cell Migration Inhibition; D002927:Cimetidine / Q000009:adverse effects* / Q000276:immunology; D004342:Drug Hypersensitivity / Q000276:immunology; D006146:Guanidines / Q000009:adverse effects*; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II / Q000032:analysis; D006801:Humans; D007668:Kidney / Q000473:pathology; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008297:Male; D009132:Muscles / Q000473:pathology; D009220:Myositis / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D009395:Nephritis, Interstitial / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D013601:T-Lymphocytes; D006377:T-Lymphocytes, Helper-Inducer; D050378:T-Lymphocytes, Regulatory
D006146:Guanidines; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D002927:Cimetidine